Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Xencor (XNCR)

Xencor Q4 revenue falls to $28.2 million; net loss narrows to $6.7 million

Mixed Impact 3 of 5 earnings Written later

Xencor reported fourth quarter and full year 2025 results on February 25, 2026. Full year revenue rose to $125.6 million from $110.5 million, but fourth quarter revenue fell to $28.2 million from $52.8 million, and the fourth quarter operating loss widened to $53.6 million from $13.2 million. Net losses narrowed, driven mainly by other income, net, which included gains from marketable equity securities.

Key points

  • Q4 2025 revenue was $28.2 million vs. $52.8 million in Q4 2024; full year 2025 revenue was $125.6 million vs. $110.5 million.
  • Q4 2025 net loss attributable to Xencor was $6.7 million, or $(0.09) per share, vs. $45.6 million, or $(0.62), a year earlier.
  • Full year 2025 net loss attributable to Xencor was $91.9 million, or $(1.24) per share, vs. $232.6 million, or $(3.58), in 2024.
  • Xencor expects to end 2026 with $400 million to $430 million in cash, cash equivalents and marketable debt securities, versus $610.8 million at December 31, 2025.

The filing

CompanyXencor (XNCR)
Form8-K, current report
Filed with the SECFeb 25, 2026, 4:01 PM ET
Accession number0001326732-26-000014

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 25, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.